Emerging technologies for cardiac tissue engineering and artificial hearts

[1]  G. Wallace,et al.  Development of 3D printable graphene oxide based bio-ink for cell support and tissue engineering , 2022, Frontiers in Bioengineering and Biotechnology.

[2]  Changyong Wang,et al.  A Conductive Bioengineered Cardiac Patch for Myocardial Infarction Treatment by Improving Tissue Electrical Integrity , 2022, Advanced healthcare materials.

[3]  J. Fradette,et al.  Biofabrication of Sodium Alginate Hydrogel Scaffolds for Heart Valve Tissue Engineering , 2022, International journal of molecular sciences.

[4]  K. Parker,et al.  Recreating the heart’s helical structure-function relationship with focused rotary jet spinning , 2022, Science.

[5]  S. Jana,et al.  Strategies for development of decellularized heart valve scaffolds for tissue engineering. , 2022, Biomaterials.

[6]  Gaoyang Guo,et al.  Development of Innovative Biomaterials and Devices for the Treatment of Cardiovascular Diseases , 2022, Advanced materials.

[7]  M. Khodaei,et al.  Electro-conductive 3D printed polycaprolactone/gold nanoparticles nanocomposite scaffolds for myocardial tissue engineering. , 2022, Journal of the mechanical behavior of biomedical materials.

[8]  J. Lewis,et al.  Programming Cellular Alignment in Engineered Cardiac Tissue via Bioprinting Anisotropic Organ Building Blocks , 2022, Advanced materials.

[9]  A. Shamloo,et al.  Tubular TPU/SF nanofibers covered with chitosan-based hydrogels as small-diameter vascular grafts with enhanced mechanical properties , 2022, Scientific Reports.

[10]  Paola Sanjuan‐Alberte,et al.  Electrospun piezoelectric scaffolds for cardiac tissue engineering. , 2022, Biomaterials advances.

[11]  N. Cao,et al.  Reprogramming of fibroblasts into expandable cardiovascular progenitor cells via small molecules in xeno-free conditions , 2022, Nature Biomedical Engineering.

[12]  Mitchell A. Kuss,et al.  Tri‐Layered and Gel‐Like Nanofibrous Scaffolds with Anisotropic Features for Engineering Heart Valve Leaflets , 2022, Advanced healthcare materials.

[13]  Mary E. Haas,et al.  Association of Habitual Alcohol Intake With Risk of Cardiovascular Disease , 2022, JAMA network open.

[14]  Karina H. Nakayama,et al.  Decellularization Strategies for Regenerating Cardiac and Skeletal Muscle Tissues , 2022, Frontiers in Bioengineering and Biotechnology.

[15]  Wenguang Liu,et al.  Functional hydrogels for the treatment of myocardial infarction , 2022, NPG Asia Materials.

[16]  D. Hutmacher,et al.  Spatially Heterogeneous Tubular Scaffolds for In Situ Heart Valve Tissue Engineering Using Melt Electrowriting , 2022, Advanced Functional Materials.

[17]  Benjamin Bowe,et al.  Long-term cardiovascular outcomes of COVID-19 , 2022, Nature Medicine.

[18]  Charlie C. L. Wang,et al.  A multi-axis robot-based bioprinting system supporting natural cell function preservation and cardiac tissue fabrication , 2022, Bioactive materials.

[19]  Changyou Gao,et al.  Multifunctional elastomer cardiac patches for preventing left ventricle remodeling after myocardial infarction in vivo. , 2022, Biomaterials.

[20]  R. Passier,et al.  Generation and Culture of Cardiac Microtissues in a Microfluidic Chip with a Reversible Open Top Enables Electrical Pacing, Dynamic Drug Dosing and Endothelial Cell Co-Culture , 2021, bioRxiv.

[21]  M. Radisic,et al.  A framework for developing sex-specific engineered heart models , 2021, Nature Reviews Materials.

[22]  F. Benesch-Lee,et al.  Hyaluronic Acid Regulates Heart Valve Interstitial Cell Contraction in Fibrin-based Scaffolds. , 2021, Acta biomaterialia.

[23]  D. Davis,et al.  State‐of‐play for cellular therapies in cardiac repair and regeneration , 2021, Stem cells.

[24]  Changyong Wang,et al.  Natural Melanin/Alginate Hydrogels Achieve Cardiac Repair through ROS Scavenging and Macrophage Polarization , 2021, Advanced science.

[25]  J. Qian,et al.  Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration. , 2021, Biomaterials.

[26]  Baolin Guo,et al.  3D bioprinting in cardiac tissue engineering , 2021, Theranostics.

[27]  G. Zapata-Sudo,et al.  Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases , 2021, International journal of molecular sciences.

[28]  Jianhua Liu,et al.  Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries , 2021, Bioactive materials.

[29]  Yuanjin Zhao,et al.  Induced cardiomyocytes-integrated conductive microneedle patch for treating myocardial infarction , 2021 .

[30]  G. Vunjak‐Novakovic,et al.  Harnessing organs-on-a-chip to model tissue regeneration. , 2021, Cell stem cell.

[31]  Junjun Li,et al.  Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model. , 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[32]  Xiaodong Cao,et al.  Bioactive glass activates VEGF paracrine signaling of cardiomyocytes to promote cardiac angiogenesis. , 2021, Materials science & engineering. C, Materials for biological applications.

[33]  A. Tamayol,et al.  Biofabrication of natural hydrogels for cardiac, neural, and bone Tissue engineering Applications , 2021, Bioactive materials.

[34]  R. Choi,et al.  Ceramides and other sphingolipids as drivers of cardiovascular disease , 2021, Nature Reviews Cardiology.

[35]  R. Augustine,et al.  Stem cell-based approaches in cardiac tissue engineering: controlling the microenvironment for autologous cells. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[36]  T. Dvir,et al.  One‐Step 3D Printing of Heart Patches with Built‐In Electronics for Performance Regulation , 2021, Advanced science.

[37]  Sung Yun Hann,et al.  4D Printed Cardiac Construct with Aligned Myofibers and Adjustable Curvature for Myocardial Regeneration. , 2021, ACS applied materials & interfaces.

[38]  Haitao Liu,et al.  3D printing of tissue engineering scaffolds: a focus on vascular regeneration , 2021, Bio-design and manufacturing.

[39]  H. Baumgartner,et al.  The year in cardiovascular medicine 2020: valvular heart disease , 2021, European heart journal.

[40]  Nanbo Liu,et al.  Advances in 3D bioprinting technology for cardiac tissue engineering and regeneration , 2020, Bioactive materials.

[41]  Qian Yu,et al.  Release of VEGF and BMP9 from injectable alginate based composite hydrogel for treatment of myocardial infarction , 2020, Bioactive materials.

[42]  B. Leal,et al.  Vascular Tissue Engineering: Polymers and Methodologies for Small Caliber Vascular Grafts , 2021, Frontiers in Cardiovascular Medicine.

[43]  P. Zorlutuna,et al.  Electrically conductive 3D printed Ti3C2Tx MXene-PEG composite constructs for cardiac tissue engineering. , 2020, Acta biomaterialia.

[44]  R. Cameron,et al.  Modulating hESC-derived cardiomyocyte and endothelial cell function with triple-helical peptides for heart tissue engineering. , 2020, Biomaterials.

[45]  Samin K. Sharma,et al.  Cardiac procedural myocardial injury, infarction, and mortality in patients undergoing elective percutaneous coronary intervention: a pooled analysis of patient-level data. , 2020, European heart journal.

[46]  Deok‐Ho Kim,et al.  3D Bioprinting of Mechanically Tuned Bioinks derived from Cardiac Decellularized Extracellular Matrix. , 2020, Acta biomaterialia.

[47]  J. Jacot,et al.  Engineering Myocardium for Heart Regeneration—Advancements, Considerations, and Future Directions , 2020, Frontiers in Cardiovascular Medicine.

[48]  L. Fields,et al.  Engineered cell-degradable poly(2-alkyl-2-oxazoline) hydrogel for epicardial placement of mesenchymal stem cells for myocardial repair , 2020, Biomaterials.

[49]  Yu Song,et al.  Silk‐Based Biomaterials for Cardiac Tissue Engineering , 2020, Advanced healthcare materials.

[50]  Randall J. Lee,et al.  Injectable Drug‐Releasing Microporous Annealed Particle Scaffolds for Treating Myocardial Infarction , 2020, Advanced functional materials.

[51]  M. Schwerzmann,et al.  2020 ESC Guidelines for the management of adult congenital heart disease. , 2020, European heart journal.

[52]  A. Urbanska,et al.  Electrospinning for tissue engineering applications , 2020 .

[53]  M. Gatzoulis,et al.  Heart transplantation at a single tertiary adult congenital heart disease centre: Too little, too late? , 2020, International journal of cardiology.

[54]  Doris A Taylor,et al.  Tissue-engineered human embryonic stem cell-containing cardiac patches: evaluating recellularization of decellularized matrix , 2020, Journal of tissue engineering.

[55]  Wuqiang Zhu,et al.  Nanoparticle-Mediated Drug Delivery for Treatment of Ischemic Heart Disease , 2020, Frontiers in Bioengineering and Biotechnology.

[56]  Sung Yun Hann,et al.  4D physiologically adaptable cardiac patch: A 4-month in vivo study for the treatment of myocardial infarction , 2020, Science Advances.

[57]  A. B. Van de Walle,et al.  Flow with variable pulse frequencies accelerates vascular recellularization and remodeling of a human bioscaffold. , 2020, Journal of biomedical materials research. Part A.

[58]  R. Virmani,et al.  Vulnerable plaques and patients: state-of-the-art. , 2020, European heart journal.

[59]  A. Marsden,et al.  Spontaneous reversal of stenosis in tissue-engineered vascular grafts , 2020, Science Translational Medicine.

[60]  D. K. Arrell,et al.  Cardiopoietic stem cell therapy restores infarction-altered cardiac proteome , 2020, npj Regenerative Medicine.

[61]  D. Cho,et al.  In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair , 2020, Science Advances.

[62]  Guoyou Huang,et al.  Solvent-Free Fabrication of Carbon Nanotube/Silk Fibroin Electrospun Matrices for Enhancing Cardiomyocyte Functionalities. , 2020, ACS biomaterials science & engineering.

[63]  T. Dvir,et al.  Electrospun Fibrous PVDF‐TrFe Scaffolds for Cardiac Tissue Engineering, Differentiation, and Maturation , 2020, Advanced Materials Technologies.

[64]  Shu‐hong Li,et al.  A conductive cell-delivery construct as a bioengineered patch that can improve electrical propagation and synchronize cardiomyocyte contraction for heart repair. , 2020, Journal of controlled release : official journal of the Controlled Release Society.

[65]  L. Niklason,et al.  Tissue-Engineered Vascular Grafts with Advanced Mechanical Strength from Human iPSCs. , 2020, Cell stem cell.

[66]  Yi Hong,et al.  Current Advances in Biodegradable Synthetic Polymer based Cardiac Patches. , 2020, Journal of biomedical materials research. Part A.

[67]  Sebastien G M Uzel,et al.  Biomanufacturing of organ-specific tissues with high cellular density and embedded vascular channels , 2019, Science Advances.

[68]  R. Khouzam,et al.  A Comparative Analysis of Mitraclip Versus Mitral Valve-In-Valve Replacement for High-Risk Patients With Severe Mitral Regurgitation After Transcatheter Aortic Valve Replacement. , 2019, Current problems in cardiology.

[69]  Zhen Gu,et al.  Cardiac cell–integrated microneedle patch for treating myocardial infarction , 2018, Science Advances.

[70]  P. Ma,et al.  Interwoven Aligned Conductive Nanofiber Yarn/Hydrogel Composite Scaffolds for Engineered 3D Cardiac Anisotropy. , 2017, ACS nano.

[71]  I. Domian,et al.  Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease. , 2017, Trends in cell biology.

[72]  N. Bursac,et al.  Tissue-engineered 3-dimensional (3D) microenvironment enhances the direct reprogramming of fibroblasts into cardiomyocytes by microRNAs , 2016, Scientific Reports.

[73]  Teruo Okano,et al.  Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration , 2014, Scientific Reports.

[74]  N. Bursac,et al.  Controlling the structural and functional anisotropy of engineered cardiac tissues , 2014, Biofabrication.

[75]  Kumaraswamy Nanthakumar,et al.  Design and formulation of functional pluripotent stem cell-derived cardiac microtissues , 2013, Proceedings of the National Academy of Sciences.

[76]  Jiyong Jin,et al.  Transplantation of mesenchymal stem cells within a poly(lactide‐co‐ɛ‐caprolactone) scaffold improves cardiac function in a rat myocardial infarction model , 2009, European journal of heart failure.

[77]  J. Huard,et al.  Muscle-derived stem cells for tissue engineering and regenerative therapy. , 2007, Biomaterials.

[78]  Diane Hoffman-Kim,et al.  Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves. , 2005, Tissue engineering.